223 related articles for article (PubMed ID: 32201399)
1. Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications.
Huang X; Yang C; Wang J; Sun T; Xiong H
Aging (Albany NY); 2020 Mar; 12(6):4970-4995. PubMed ID: 32201399
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
[TBL] [Abstract][Full Text] [Related]
4. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
6. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
[TBL] [Abstract][Full Text] [Related]
7. The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
Ahn SM; Haq F; Park I; Nault JC; Zucman-Rossi J; Yu E
BMC Cancer; 2018 May; 18(1):571. PubMed ID: 29776391
[TBL] [Abstract][Full Text] [Related]
8. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Hoshida Y; Nijman SM; Kobayashi M; Chan JA; Brunet JP; Chiang DY; Villanueva A; Newell P; Ikeda K; Hashimoto M; Watanabe G; Gabriel S; Friedman SL; Kumada H; Llovet JM; Golub TR
Cancer Res; 2009 Sep; 69(18):7385-92. PubMed ID: 19723656
[TBL] [Abstract][Full Text] [Related]
9. HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
He H; Chen D; Cui S; Wu G; Piao H; Wang X; Ye P; Jin S
BMC Med Genomics; 2020 Aug; 13(1):118. PubMed ID: 32831081
[TBL] [Abstract][Full Text] [Related]
10. Systemic transcriptome analysis of hepatocellular carcinoma.
Yu CB; Zhu LY; Wang YG; Li F; Zhang XY; Dai WJ
Tumour Biol; 2016 Oct; 37(10):13323-13331. PubMed ID: 27460080
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
[TBL] [Abstract][Full Text] [Related]
12. Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma.
Liu G; Dong C; Liu L
PLoS One; 2016; 11(11):e0165457. PubMed ID: 27806083
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
[TBL] [Abstract][Full Text] [Related]
14. Computational analysis of TP53 vs. CTNNB1 mutations in hepatocellular carcinoma suggests distinct cancer subtypes with differential gene expression profiles and chromatin states.
Biterge Süt B
Comput Biol Chem; 2020 Dec; 89():107404. PubMed ID: 33096424
[TBL] [Abstract][Full Text] [Related]
15. The underlying pathophysiology association between the Type 2-diabetic and hepatocellular carcinoma.
Wei H; Wang J; Li W; Ma R; Xu Z; Luo Z; Lu Y; Zhang X; Long X; Pu J; Tang Q
J Cell Physiol; 2019 Jul; 234(7):10835-10841. PubMed ID: 30585632
[TBL] [Abstract][Full Text] [Related]
16. Metabolism-associated molecular classification of hepatocellular carcinoma.
Yang C; Huang X; Liu Z; Qin W; Wang C
Mol Oncol; 2020 Apr; 14(4):896-913. PubMed ID: 31955511
[TBL] [Abstract][Full Text] [Related]
17. A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma.
Zhang T; Gu J; Wang X; Lu Y; Cai K; Li H; Nie Y; Chen X; Wang J
Front Immunol; 2023; 14():1140201. PubMed ID: 36936935
[TBL] [Abstract][Full Text] [Related]
18. Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma.
Gérard C; Di-Luoffo M; Gonay L; Caruso S; Couchy G; Loriot A; Castven D; Tao J; Konobrocka K; Cordi S; Monga SP; Hanert E; Marquardt JU; Zucman-Rossi J; Lemaigre FP
J Hepatol; 2019 Aug; 71(2):323-332. PubMed ID: 30953666
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Bai Y; Tong W; Xie F; Zhu L; Wu H; Shi R; Wang L; Yang L; Liu Z; Miao F; Zhao Q; Zhang Y
Aging (Albany NY); 2021 Jul; 13(13):17592-17606. PubMed ID: 34237708
[TBL] [Abstract][Full Text] [Related]
20. Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes.
Bidkhori G; Benfeitas R; Klevstig M; Zhang C; Nielsen J; Uhlen M; Boren J; Mardinoglu A
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11874-E11883. PubMed ID: 30482855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
